Washington, D.C - The founder and former Chief Executive Officer (CEO) Ruthia He of Done Global Inc., a California-based digital mental health company, was sentenced today to six years in prison and a fine of $1 million for orchestrating a scheme that used her company’s technology platform, compensation structure, and...

WASHINGTON – As the United States prepares to host millions of international visitors for the FIFA World Cup 2026™, the U.S. Drug Enforcement Administration is committed to ensuring the safety of fans, teams, and communities during this historic, global sporting event. DEA is focused on keeping visitors and communities safe...

WASHINGTON D.C. - A federal jury in the Southern District of Texas convicted a Texas physician yesterday for unlawfully distributing more than a million pills of opioids and other dangerous controlled substances. “Medical physicians who exploit their prescribing authority for profit over patient care break an inherent trust with their...

WASHINGTON – Today, the U.S. Drug Enforcement Administration, with the cooperation of the U.S. Attorney’s Office for the Eastern District of New York, announced the seizure of more than 200 website domains tied to an India-based transnational criminal organization (TCO) working within the United States and allegedly responsible for at...

SAN FRANCISCO – For a third consecutive year, the U.S. Drug Enforcement Administration and NFL Alumni Health (NFLAH) are joining forces to raise awareness about the dangers of fentanyl and spreading a critical message: One Pill Can Kill . Building on the success of the last two year, this collaboration...

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...

WASHINGTON – The U.S. Drug Enforcement Administration, in partnership with the Department of Health and Human Services (HHS), has issued a Fourth Temporary Extension of the COVID-19 Telemedicine Flexibilities for the Prescription of Controlled Medications , extending the current telemedicine flexibilities through December 31, 2026. Under these telemedicine flexibilities, DEA-registered...

WASHINGTON –The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription Drug Take...

WASHINGTON – The U.S. Drug Enforcement Administration, in partnership with the Benevolent and Protective Order of the Elks, will release Season 5 of the video podcast Awkward Conversations on September 24, 2025. The unscripted Season 5 of Awkward Conversations is once again hosted by Jodie Sweetin (Full House, Fuller House...

WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...